Author:
Mucchetti Marta,Maimeri Nicolò,Nardelli Pasquale
Publisher
Springer International Publishing
Reference36 articles.
1. US Food and Drugs Administration (2017) FDA Press releas. FDA clears test to help manage antibiotic treatment for lower respiratory tract infections and sepsis. https://www.fda.gov/news-events/press-announcements/fda-clears-test-help-manage-antibiotic-treatment-lower-respiratory-tract-infections-and-sepsis. Accessed Mar 2020.
2. Schuetz P, Beishuizen A, Broyles M, Ferrer R, Gavazzi G, Gluck EH, González Del Castillo J, Jensen J, Kanizsai PL, Kwa ALH, Krueger S, Luyt C, Oppert M, Plebani M, Shlyapnikov SA, Toccafondi G, Townsend J, Welte T, Saeed K. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clin Chem Lab Med. 2019;57:1308–18.
3. Hamade B, Huang DT. Procalcitonin: Where are we now? Crit Care Clin. 2020;36:23–40.
4. de Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE, Loef BG, Dormans T, van Melsen GC, Kluiters YC, Kemperman H, van den Elsen MJ, Schouten JA, Streefkerk J, Krabbe HG, Kieft H, Kluge GH, van Dam VC, van Pelt J, Bormans L, Otten MB. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016;16:819–27.
5. Daubin C, Valette X, Thiollière F, Mira J, Hazera P, Annane D, Labbe V, Floccard B, Fournel F, Terzi N, Du Cheyron D, Parienti J. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study. Intensive Care Med. 2018;44:428–37.